BSX
$71.20
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and tre...
Recent News
Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus
Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX) over disclosures about its U.S. Electrophysiology segment. Plaintiffs allege the company misled investors about growth prospects and competitive threats in this business line. The lawsuits follow disappointing financial results and guidance that highlighted pressures in Electrophysiology. Legal claims focus on supposed misrepresentations by company leadership regarding business fundamentals and...
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.